Literature DB >> 25504573

Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission.

Jimok Kim1, Yong Li.   

Abstract

KEY POINTS: The effects of cannabinoids are primarily mediated by two types of cannabinoid receptors, CB1 receptors in the nervous system and CB2 receptors in the immune system. Recent evidence indicates that CB2 receptors are also widely expressed in the brain and involved in neuropsychiatric functions, such as schizophrenia-like behaviours, anxiety, memory, vomiting and pain. The cellular mechanisms by which CB2 receptors regulate neuronal functions are unknown. We show that chronic activation of CB2 receptors in the hippocampus for 7-10 days increases excitatory synaptic transmission, whereas short-term activation of CB2 receptors has little effect on synaptic activity. This study reveals a novel role of CB2 receptors in the brain, which is clearly distinct from that of CB1 receptors, and thus, will help us to understand better the diverse effects of cannabinoids in the nervous system. ABSTRACT: The roles of CB1 cannabinoid receptors in regulating neuronal activity have been extensively characterized. Although early studies show that CB1 receptors are present in the nervous system and CB2 cannabinoid receptors are in the immune system, recent evidence indicates that CB2 receptors are also expressed in the brain. Activation or blockade of CB2 receptors in vivo induces neuropsychiatric effects, but the cellular mechanisms of CB2 receptor function are unclear. The aim of this study is to determine how activation of CB2 receptors present in the hippocampus regulates synaptic function. Here, we show that when organotypic cultures of rodent hippocampal slices were treated with a CB2 receptor agonist (JWH133 or GP1a) for 7-10 days, quantal glutamate release became more frequent and spine density was increased via extracellular signal-regulated kinases. Chronic intraperitoneal injection of JWH133 into mice also increased excitatory synaptic transmission. These effects were blocked by a CB2 receptor antagonist (SR144528) or absent from hippocampal slices of CB2 receptor knock-out mice. This study reveals a novel cellular function of CB2 cannabinoid receptors in the hippocampus and provides insights into how cannabinoid receptor subtypes diversify the roles of cannabinoids in the brain.
© 2014 The Authors. The Journal of Physiology © 2014 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25504573      PMCID: PMC4398527          DOI: 10.1113/jphysiol.2014.286633

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  71 in total

1.  Released fraction and total size of a pool of immediately available transmitter quanta at a calyx synapse.

Authors:  R Schneggenburger; A C Meyer; E Neher
Journal:  Neuron       Date:  1999-06       Impact factor: 17.173

2.  Multiple forms of synaptic plasticity triggered by selective suppression of activity in individual neurons.

Authors:  Juan Burrone; Michael O'Byrne; Venkatesh N Murthy
Journal:  Nature       Date:  2002-11-28       Impact factor: 49.962

Review 3.  Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids.

Authors:  Bradley E Alger
Journal:  Prog Neurobiol       Date:  2002-11       Impact factor: 11.685

4.  Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses.

Authors:  Qiang Zhou; Koichi J Homma; Mu-ming Poo
Journal:  Neuron       Date:  2004-12-02       Impact factor: 17.173

Review 5.  Extracellular signal-regulated kinase, synaptic plasticity, and memory.

Authors:  E Thiels; E Klann
Journal:  Rev Neurosci       Date:  2001       Impact factor: 4.353

6.  Presynaptic specificity of endocannabinoid signaling in the hippocampus.

Authors:  R I Wilson; G Kunos; R A Nicoll
Journal:  Neuron       Date:  2001-08-16       Impact factor: 17.173

7.  Determination and characterization of a cannabinoid receptor in rat brain.

Authors:  W A Devane; F A Dysarz; M R Johnson; L S Melvin; A C Howlett
Journal:  Mol Pharmacol       Date:  1988-11       Impact factor: 4.436

Review 8.  Cannabinoid signalling.

Authors:  Dirk G Demuth; Areles Molleman
Journal:  Life Sci       Date:  2005-08-18       Impact factor: 5.037

Review 9.  Mitogen-activated protein kinases in synaptic plasticity and memory.

Authors:  J David Sweatt
Journal:  Curr Opin Neurobiol       Date:  2004-06       Impact factor: 6.627

10.  Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory.

Authors:  Cristina Mazzucchelli; Chiara Vantaggiato; Alessandro Ciamei; Stefania Fasano; Pavel Pakhotin; Wojciech Krezel; Hans Welzl; David P Wolfer; Gilles Pagès; Olga Valverde; Anne Marowsky; Annamaria Porrazzo; Paul C Orban; Rafael Maldonado; Markus U Ehrengruber; Vincenzo Cestari; Hans-Peter Lipp; Paul F Chapman; Jacques Pouysségur; Riccardo Brambilla
Journal:  Neuron       Date:  2002-05-30       Impact factor: 17.173

View more
  35 in total

1.  Intracellular GPCRs Play Key Roles in Synaptic Plasticity.

Authors:  Yuh-Jiin I Jong; Steven K Harmon; Karen L O'Malley
Journal:  ACS Chem Neurosci       Date:  2018-02-16       Impact factor: 4.418

Review 2.  Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Authors:  Evan C Rosenberg; Pabitra H Patra; Benjamin J Whalley
Journal:  Epilepsy Behav       Date:  2017-02-09       Impact factor: 2.937

3.  High on 'chronic': an unexpected route to cannabinoid-induced synaptic plasticity.

Authors:  Brian N Mathur
Journal:  J Physiol       Date:  2015-02-15       Impact factor: 5.182

4.  Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus.

Authors:  Y Li; J Kim
Journal:  Neuroscience       Date:  2015-10-26       Impact factor: 3.590

Review 5.  Brain cannabinoid receptor 2: expression, function and modulation.

Authors:  De-Jie Chen; Ming Gao; Fen-Fei Gao; Quan-Xi Su; Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2017-01-09       Impact factor: 6.150

6.  Interaction between NMDA and CB2 function in the dorsal hippocampus on memory consolidation impairment: an isobologram analysis.

Authors:  Mohammad Nasehi; Marziyeh Hajikhani; Mohaddeseh Ebrahimi-Ghiri; Mohammad-Reza Zarrindast
Journal:  Psychopharmacology (Berl)       Date:  2016-11-17       Impact factor: 4.530

Review 7.  The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2.

Authors:  Makenzie L Fulmer; Douglas P Thewke
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2018

Review 8.  Progress in brain cannabinoid CB2 receptor research: From genes to behavior.

Authors:  Chloe J Jordan; Zheng-Xiong Xi
Journal:  Neurosci Biobehav Rev       Date:  2019-01-03       Impact factor: 8.989

9.  CB2R induces a protective response for epileptic seizure via the PI3K 110α-AKT signaling pathway.

Authors:  Qingjun Cao; Xueyan Liu; Fenghua Yang; Hua Wang
Journal:  Exp Ther Med       Date:  2018-09-24       Impact factor: 2.447

10.  Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.

Authors:  A Vanessa Stempel; Alexander Stumpf; Hai-Ying Zhang; Tuğba Özdoğan; Ulrike Pannasch; Anne-Kathrin Theis; David-Marian Otte; Alexandra Wojtalla; Ildikó Rácz; Alexey Ponomarenko; Zheng-Xiong Xi; Andreas Zimmer; Dietmar Schmitz
Journal:  Neuron       Date:  2016-04-28       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.